Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia.
Beelen, DW; Arnold, R; Stelljes, M; Alakel, N; Brecht, A; Bug, G; Bunjes, D; Faul, C; Finke, J; Franke, GN; Holler, E; Kobbe, G; Kröger, N; Rösler, W; Scheid, C; Schönland, S; Stadler, M; Tischer, J; Wagner-Drouet, E; Wendelin, K; Brüggemann, M; Reiser, L; Hoelzer, D; Gökbuget, N;
Transplant Cell Ther. 2022; 28(12): 834-842.
Originalarbeiten (Zeitschrift)

Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 years.
Kuerzel, S; Blaudszun, AR; Stahl, L; Herbst, R; Kroschinsky, F; Birkmann, J; Haenel, A; Schaefer-Eckart, K; Ehninger, G; Fiedler, F; Bornhaeuser, M; Fricke, S; Haenel, M
J Cancer Res Clin Oncol. 2022; 148(5):1171-1181
Originalarbeiten (Zeitschrift)

Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Kunadt, D; Stasik, S; Metzeler, KH; Rollig, C; Schliemann, C; Greif, PA; Spiekermann, K; Rothenberg-Thurley, M; Krug, U; Braess, J; Kramer, A; Hochhaus, A; Scholl, S; Hilgendorf, I; Brummendorf, TH; Jost, E; Steffen, B; Bug, G; Einsele, H; Gorlich, D; Sauerland, C; Schafer-Eckart, K; Krause, SW; Hanel, M; Hanoun, M; Kaufmann, M; Wormann, B; Kramer, M; Sockel, K; Egger-Heidrich, K; Herold, T; Ehninger, G; Burchert, A; Platzbecker, U; Berdel, WE; Muller-Tidow, C; Hiddemann, W; Serve, H; Stelljes, M; Baldus, CD; Neubauer, A; Schetelig, J; Thiede, C; Bornhauser, M; Middeke, JM; Stolzel, F
J HEMATOL ONCOL. 2022; 15(1): 126
Originalarbeiten (Zeitschrift)

Infection as a Differential Diagnosis of Solid Retroperitoneal Masses: A Case Series and Review of the Literature.
Levidou, G; Klein, T; Schaefer-Eckart, K; Huettenbrink, C; Manava, P;
Cureus. 2022; 14(5): e24656
Übersichtsarbeiten

The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy.
Wiesinger, AM; Bigger, B; Giugliani, R; Scarpa, M; Moser, T; Lampe, C; Kampmann, C; Lagler, FB;
FRONT PHARMACOL. 2022; 13: 863667
Übersichtsarbeiten

Sarcopenia Screening Allows Identifying High-Risk Patients for Allogenic Stem Cell Transplantation.
Kirsten, J; Wais, V; Schulz, SVW; Sala, E; Treff, G; Bunjes, D; Steinacker, JM;
Cancers (Basel). 2021; 13(8):
Originalarbeiten (Zeitschrift)

Antibiotic Prophylaxis or Granulocyte-Colony Stimulating Factor Support in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.
Klein, EM; Sauer, S; Klein, S; Tichy, D; Benner, A; Bertsch, U; Brandt, J; Kimmich, C; Goldschmidt, H; Muller-Tidow, C; Jordan, K; Giesen, N
CANCERS. 2021; 13(14):
Originalarbeiten (Zeitschrift)

Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial.
Klein, EM; Tichy, D; Salwender, HJ; Mai, EK; Duerig, J; Weisel, KC; Benner, A; Bertsch, U; Akhavanpoor, M; Besemer, B; Munder, M; Lindemann, HW; Hose, D; Seckinger, A; Luntz, S; Jauch, A; Elmaagacli, A; Fuhrmann, S; Brossart, P; Goerner, M; Bernhard, H; Raab, MS; Blau, IW; Haenel, M; Scheid, C; Goldschmidt, H
CANCERS. 2021; 13(19):
Originalarbeiten (Zeitschrift)

Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation.
Wagner-Drouet, E; Teschner, D; Wolschke, C; Schafer-Eckart, K; Gartner, J; Mielke, S; Schreder, M; Kobbe, G; Hilgendorf, I; Klein, S; Verbeek, M; Ditschkowski, M; Koch, M; Lindemann, M; Schmidt, T; Rascle, A; Barabas, S; Deml, L; Wagner, R; Wolff, D
DIAGNOSTICS. 2021; 11(2):
Originalarbeiten (Zeitschrift)

Current and Emerging Therapies for Mucopolysaccharidoses.
Lagler, FB;
Handb Exp Pharmacol. 2020; 261: 39-56.
Originalarbeiten (Zeitschrift)

The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis.
Mytilineos, D; Tsamadou, C; Neuchel, C; Platzbecker, U; Bunjes, D; Schub, N; Wagner-Drouet, E; Wulf, G; Kroger, N; Murawski, N; Einsele, H; Schaefer-Eckart, K; Freitag, S; Casper, J; Kaufmann, M; Durholt, M; Hertenstein, B; Klein, S; Ringhoffer, M; Mueller, CR; Frank, S; Schrezenmeier, H; Fuerst, D; Mytilineos, J
FRONT IMMUNOL. 2020; 11: 614976
Originalarbeiten (Zeitschrift)

Immunological consequences of "immune reconstitution therapy" in multiple sclerosis: A systematic review.
Sellner, J; Rommer, PS
AUTOIMMUN REV. 2020; 19(4): 102492
Übersichtsarbeiten

Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas.
Wagner, SM; Melchardt, T; Egle, A; Magnes, T; Skrabs, C; Staber, P; Simonitsch-Klupp, I; Panny, M; Lehner, B; Greil, R; Keil, F; Jäger, U; Sillaber, C;
Eur J Haematol. 2020; 104(3):251-258
Originalarbeiten (Zeitschrift)

Lipocalin-2 levels in acute and chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Hermann, A; Winkler, A; Paschen, C; Kuzmina, Z; Hladik, A; Icme, S; Robak, O;
Exp Hematol. 2019; 74: 25-32.e1.
Originalarbeiten (Zeitschrift)

Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells.
Menon, V; Thomas, R; Elgueta, C; Horl, M; Osborn, T; Hallett, PJ; Bartos, M; Isacson, O; Pruszak, J;
Stem Cells. 2019; 37(10):1293-1306
Originalarbeiten (Zeitschrift)

Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group.
Jurinovic, V; Metzner, B; Pfreundschuh, M; Schmitz, N; Wandt, H; Keller, U; Dreger, P; Dreyling, M; Hiddemann, W; Unterhalt, M; Hoster, E; Weigert, O
BIOL BLOOD MARROW TR. 2018; 24(6): 1172-1179.
Originalarbeiten (Zeitschrift)

Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal Cells
Oeller, M; Laner-Plamberger, S; Hochmann, S; Ketterl, N; Feichtner, M; Brachtl, G; Hochreiter, A; Scharler, C; Bieler, L; Romanelli, P; Couillard-Despres, S; Russe, E; Schallmoser, K; Strunk, D
THERANOSTICS. 2018; 8(5): 1421-1434.
Originalarbeiten (Zeitschrift)

A novel HLA-C variant, HLA-C*04:01:85, detected by next generation sequencing.
Pruszak, J; Bernheiden, M; Emmerich, F;
HLA. 2018;
Kurzberichte/Notes

Microbiologic Diagnostic Workup of Acute Respiratory Failure with Pulmonary Infiltrates after Allogeneic Hematopoietic Stem Cell Transplantation: Findings in the Era of Molecular- and Biomarker-Based Assays.
Wohlfarth, P; Turki, AT; Steinmann, J; Fiedler, M; Steckel, NK; Beelen, DW; Liebregts, T;
Biol Blood Marrow Transplant. 2018; 24(8): 1707-1714.
Originalarbeiten (Zeitschrift)

Survival outcomes of patients with germ cell tumors treated with high-dose chemotherapy for refractory or relapsing disease.
Zschäbitz, S; Distler, FA; Krieger, B; Wuchter, P; Schäfer-Eckart, K; Jenzer, M; Hohenfellner, M; Dreger, P; Haag, GM; Jäger, D; Pahernik, S; Grüllich, C;
Oncotarget. 2018; 9(32): 22537-22545.
Originalarbeiten (Zeitschrift)

Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
Brissot, E; Labopin, M; Stelljes, M; Ehninger, G; Schwerdtfeger, R; Finke, J; Kolb, HJ; Ganser, A; Schafer-Eckart, K; Zander, AR; Bunjes, D; Mielke, S; Bethge, WA; Milpied, N; Kalhs, P; Blau, IW; Kroger, N; Vitek, A; Gramatzki, M; Holler, E; Schmid, C; Esteve, J; Mohty, M; Nagler, A
J HEMATOL ONCOL. 2017; 10(1): 130
Originalarbeiten (Zeitschrift)

Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations.
Heidrich, K; Thiede, C; Schafer-Eckart, K; Schmitz, N; Aulitzky, WE; Kramer, A; Rosler, W; Hanel, M; Einsele, H; Baldus, CD; Trappe, RU; Stolzel, F; Middeke, JM; Rollig, C; Taube, F; Kramer, M; Serve, H; Berdel, WE; Ehninger, G; Bornhauser, M; Schetelig, J
ANN ONCOL. 2017; 28(11): 2793-2798.
Originalarbeiten (Zeitschrift)

Stromal Cells Act as Guardians for Endothelial Progenitors by Reducing Their Immunogenicity After Co-Transplantation.
Souidi, N; Stolk, M; Rudeck, J; Strunk, D; Schallmoser, K; Volk, HD; Seifert, M;
Stem Cells. 2017; 35(5): 1233-1245.
Originalarbeiten (Zeitschrift)

Pentraxin-3 levels in graft-versus-host disease during allogeneic hematopoietic stem cell transplantation.
Doehn, JM; Winkler, A; Kuzmina, Z; Hladik, A; Greinix, H; Knapp, S; Robak, O;
Exp Hematol. 2016; 44(10):917-923
Originalarbeiten (Zeitschrift)

Matching for the MICA-129 polymorphism is beneficial in unrelated hematopoietic stem cell transplantation.
Fuerst, D; Neuchel, C; Niederwieser, D; Bunjes, D; Gramatzki, M; Wagner, E; Wulf, G; Glass, B; Pfreundschuh, M; Einsele, H; Arnold, R; Stuhler, G; Schaefer-Eckart, K; Freitag, S; Casper, J; Kaufmann, M; Wattad, M; Hertenstein, B; Klein, S; Ringhoffer, M; Mytilineos, D; Tsamadou, C; Mueller, C; Schrezenmeier, H; Mytilineos, J;
Blood. 2016; 128(26): 3169-3176.
Originalarbeiten (Zeitschrift)

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment.
Gratwohl, A; Pfirrmann, M; Zander, A; Kröger, N; Beelen, D; Novotny, J; Nerl, C; Scheid, C; Spiekermann, K; Mayer, J; Sayer, HG; Falge, C; Bunjes, D; Döhner, H; Ganser, A; Schmidt-Wolf, I; Schwerdtfeger, R; Baurmann, H; Kuse, R; Schmitz, N; Wehmeier, A; Th Fischer, J; Ho, AD; Wilhelm, M; Goebeler, ME; Lindemann, HW; Bormann, M; Hertenstein, B; Schlimok, G; Baerlocher, GM; Aul, C; Pfreundschuh, M; Fabian, M; Staib, P; Edinger, M; Schatz, M; Fauser, A; Arnold, R; Kindler, T; Wulf, G; Rosselet, A; Hellmann, A; Schäfer, E; Prümmer, O; Schenk, M; Hasford, J; Heimpel, H; Hossfeld, DK; Kolb, HJ; Büsche, G; Haferlach, C; Schnittger, S; Müller, MC; Reiter, A; Berger, U; Saußele, S; Hochhaus, A; Hehlmann, R;
Leukemia. 2016; 30(3):562-569
Originalarbeiten (Zeitschrift)

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
Hermine, O; Hoster, E; Walewski, J; Bosly, A; Stilgenbauer, S; Thieblemont, C; Szymczyk, M; Bouabdallah, R; Kneba, M; Hallek, M; Salles, G; Feugier, P; Ribrag, V; Birkmann, J; Forstpointner, R; Haioun, C; Hänel, M; Casasnovas, RO; Finke, J; Peter, N; Bouabdallah, K; Sebban, C; Fischer, T; Dührsen, U; Metzner, B; Maschmeyer, G; Kanz, L; Schmidt, C; Delarue, R; Brousse, N; Klapper, W; Macintyre, E; Delfau-Larue, MH; Pott, C; Hiddemann, W; Unterhalt, M; Dreyling, M;
Lancet. 2016; 388(10044): 565-575.
Originalarbeiten (Zeitschrift)

Emergence of linezolid- and vancomycin-resistant Enterococcus faecium in a department for hematologic stem cell transplantation.
Krull, M; Klare, I; Ross, B; Trenschel, R; Beelen, DW; Todt, D; Steinmann, E; Buer, J; Rath, PM; Steinmann, J;
Antimicrob Resist Infect Control. 2016; 5: 31
Originalarbeiten (Zeitschrift)

Reference data on muscle volumes of healthy human pelvis and lower extremity muscles: an in vivo magnetic resonance imaging feasibility study.
Lube, J; Cotofana, S; Bechmann, I; Milani, TL; Özkurtul, O; Sakai, T; Steinke, H; Hammer, N;
Surg Radiol Anat. 2016; 38(1): 97-106.
Originalarbeiten (Zeitschrift)

Adiponectin and resistin in acute and chronic graft-vs-host disease patients undergoing allogeneic hematopoietic stem cell transplantation.
Robak, O; Kuzmina, Z; Winkler, A; Kalhs, P; Rabitsch, W; Greinix, H;
Croat Med J. 2016; 57(3):2-65
Originalarbeiten (Zeitschrift)

Reduction in subventricular zone-derived olfactory bulb neurogenesis in a rat model of Huntington"s disease is accompanied by striatal invasion of neuroblasts.
Kandasamy, M; Rosskopf, M; Wagner, K; Klein, B; Couillard-Despres, S; Reitsamer, HA; Stephan, M; Nguyen, HP; Riess, O; Bogdahn, U; Winkler, J; von Horsten, S; Aigner, L
PLoS One. 2015; 10(2):e0116069
Originalarbeiten (Zeitschrift)

Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
Nachbaur, D; Angelova, O; Orth-Holler, D; Ditlbacher, A; Lackner, M; Auberger, J; Lass-Florl, C
EUR J HAEMATOL. 2015; 94(3): 258-264.
Originalarbeiten (Zeitschrift)

Serotonergic transmission after spinal cord injury.
Nardone, R; Höller, Y; Thomschewski, A; Höller, P; Lochner, P; Golaszewski, S; Brigo, F; Trinka, E;
J Neural Transm (Vienna). 2015; 122(2):279-295
Originalarbeiten (Zeitschrift)

Mid-term results of aortic valve surgery in redo scenarios in the current practice: results from the multicentre European RECORD (REdo Cardiac Operation Research Database) initiative†.
Onorati, F; Biancari, F; De Feo, M; Mariscalco, G; Messina, A; Santarpino, G; Santini, F; Beghi, C; Nappi, G; Troise, G; Fischlein, T; Passerone, G; Heikkinen, J; Faggian, G;
Eur J Cardiothorac Surg. 2015; 47(2):269-280
Originalarbeiten (Zeitschrift)

Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.
Robak, T; Huang, H; Jin, J; Zhu, J; Liu, T; Samoilova, O; Pylypenko, H; Verhoef, G; Siritanaratkul, N; Osmanov, E; Alexeeva, J; Pereira, J; Drach, J; Mayer, J; Hong, X; Okamoto, R; Pei, L; Rooney, B; van de Velde, H; Cavalli, F;
N Engl J Med. 2015; 372(10): 944-953.
Originalarbeiten (Zeitschrift)

Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML-long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)†.
Thiel, A; Schetelig, J; Pönisch, W; Schäfer-Eckart, K; Aulitzky, W; Peter, N; Schulze, A; Maschmeyer, G; Neugebauer, S; Herbst, R; Hänel, A; Morgner, A; Kroschinsky, F; Bornhäuser, M; Lange, T; Wilhelm, M; Niederwieser, D; Ehninger, G; Fiedler, F; Hänel, M;
Ann Oncol. 2015; 26(7): 143-140.
Originalarbeiten (Zeitschrift)

Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma.
Benboubker, L; Dimopoulos, MA; Dispenzieri, A; Catalano, J; Belch, AR; Cavo, M; Pinto, A; Weisel, K; Ludwig, H; Bahlis, N; Banos, A; Tiab, M; Delforge, M; Cavenagh, J; Geraldes, C; Lee, JJ; Chen, C; Oriol, A; de la Rubia, J; Qiu, L; White, DJ; Binder, D; Anderson, K; Fermand, JP; Moreau, P; Attal, M; Knight, R; Chen, G; Van Oostendorp, J; Jacques, C; Ervin-Haynes, A; Avet-Loiseau, H; Hulin, C; Facon, T;
N Engl J Med. 2014; 371(10): 906-917.
Originalarbeiten (Zeitschrift)

Diabetes mellitus and cellular replacement therapy: Expected clinical potential and perspectives.
Berezin, AE;
World J Diabetes. 2014; 5(6):777-786
Übersichtsarbeiten

First-in-Man Clinical Results With Good Manufacturing Practice (GMP)-compliant Polypeptide-expanded Adenovirus-specific T Cells After Haploidentical Hematopoietic Stem Cell Transplantation
Geyeregger, R; Freimuller, C; Stemberger, J; Artwohl, M; Witt, V; Lion, T; Fischer, G; Lawitschka, A; Ritter, J; Hummel, M; Holter, W; Fritsch, G; Matthes-Martin, S
J IMMUNOTHER. 2014; 37(4): 245-249.
Originalarbeiten (Zeitschrift)

Mesenchymal stromal cells from the human placenta promote neovascularization in a mouse model in vivo.
Kinzer, M; Hingerl, K; Konig, J; Reinisch, A; Strunk, D; Huppertz, B; Lang, I
PLACENTA. 2014; 35(7): 517-519.
Originalarbeiten (Zeitschrift)

A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality.
Labopin, M; Gorin, NC; Polge, E; Socié, G; Gurman, G; Gluckman, E; Jindra, P; Poiré, X; Schäfer-Eckart, K; Ruutu, T; Milone, G; Arcese, W; Mohty, M; Rocha, V;
Bone Marrow Transplant. 2014; 49(3): 376-381.
Originalarbeiten (Zeitschrift)

Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas.
Korfel, A; Elter, T; Thiel, E; Hänel, M; Möhle, R; Schroers, R; Reiser, M; Dreyling, M; Eucker, J; Scholz, C; Metzner, B; Röth, A; Birkmann, J; Schlegel, U; Martus, P; Illerhaus, G; Fischer, L;
Haematologica. 2013; 98(3): 364-370.
Originalarbeiten (Zeitschrift)

Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia.
Mohr, B; Schetelig, J; Schäfer-Eckart, K; Schmitz, N; Hänel, M; Rösler, W; Frickhofen, N; Link, H; Neubauer, A; Schuler, U; Platzbecker, U; Middeke, JM; Ehninger, G; Bornhäuser, M; Schaich, M; Stölzel, F;
Br J Haematol. 2013; 161(2):237-244
Originalarbeiten (Zeitschrift)

Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation.
Ansari, M; Strunk, D; Schallmoser, K; Delcò, C; Rougemont, AL; Moll, S; Villard, J; Gumy-Pause, F; Chalandon, Y; Parvex, P; Passweg, J; Ozsahin, H; Kindler, V;
Pediatr Transplant. 2012; 16(2):131-136
Originalarbeiten (Zeitschrift)

Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial.
Dreger, P; Döhner, H; McClanahan, F; Busch, R; Ritgen, M; Greinix, H; Fink, AM; Knauf, W; Stadler, M; Pfreundschuh, M; Dührsen, U; Brittinger, G; Hensel, M; Schetelig, J; Winkler, D; Bühler, A; Kneba, M; Schmitz, N; Hallek, M; Stilgenbauer, S;
Blood. 2012; 119(21): 4851-4859.
Originalarbeiten (Zeitschrift)

The remyelination Philosopher"s Stone: stem and progenitor cell therapies for multiple sclerosis.
Jadasz, JJ; Aigner, L; Rivera, FJ; Küry, P;
Cell Tissue Res. 2012; 349(1):331-347
Übersichtsarbeiten

High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses.
Metzelder, SK; Schroeder, T; Finck, A; Scholl, S; Fey, M; Götze, K; Linn, YC; Kröger, M; Reiter, A; Salih, HR; Heinicke, T; Stuhlmann, R; Müller, L; Giagounidis, A; Meyer, RG; Brugger, W; Vöhringer, M; Dreger, P; Mori, M; Basara, N; Schäfer-Eckart, K; Schultheis, B; Baldus, C; Neubauer, A; Burchert, A;
Leukemia. 2012; 26(11):2353-2359
Originalarbeiten (Zeitschrift)

Neural stem cells for spinal cord repair.
Sandner, B; Prang, P; Rivera, FJ; Aigner, L; Blesch, A; Weidner, N;
Cell Tissue Res. 2012; 349(1):349-362
Übersichtsarbeiten

Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 cases.
Schlick, K; Aigelsreiter, A; Pichler, M; Reitter, S; Neumeister, P; Hoefler, G; Beham-Schmid, C; Linkesch, W
Onkologie. 2012; 35(7-8):447-450
Fallberichte

Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study
Wandt, H; Schaefer-Eckart, K; Wendelin, K; Pilz, B; Wilhelm, M; Thalheimer, M; Mahlknecht, U; Ho, A; Schaich, M; Kramer, M; Kaufmann, M; Leimer, L; Schwerdtfeger, R; Conradi, R; Dolken, G; Klenner, A; Hanel, M; Herbst, R; Junghanss, C; Ehninger, G
LANCET. 2012; 380(9850): 1309-1316.
Originalarbeiten (Zeitschrift)

Allogeneic bone marrow vs. peripheral blood stem cell transplantation: a long-term retrospective single-center analysis in 329 patients.
Auberger, J; Clausen, J; Kircher, B; Kropshofer, G; Lindner, B; Nachbaur, D;
Eur J Haematol. 2011; 87(6): 531-538.
Originalarbeiten (Zeitschrift)

Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study.
Schaich, M; Röllig, C; Soucek, S; Kramer, M; Thiede, C; Mohr, B; Oelschlaegel, U; Schmitz, N; Stuhlmann, R; Wandt, H; Schäfer-Eckart, K; Aulitzky, W; Kaufmann, M; Bodenstein, H; Tischler, J; Ho, A; Krämer, A; Bornhäuser, M; Schetelig, J; Ehninger, G;
J Clin Oncol. 2011; 29(19): 2696-2702.
Originalarbeiten (Zeitschrift)

Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioning.
Casper, J; Wolff, D; Knauf, W; Blau, IW; Ruutu, T; Volin, L; Wandt, H; Schäfer-Eckart, K; Holowiecki, J; Giebel, S; Aschan, J; Zander, AR; Kröger, N; Hilgendorf, I; Baumgart, J; Mylius, HA; Pichlmeier, U; Freund, M;
J Clin Oncol. 2010; 28(20): 3344-3351.
Originalarbeiten (Zeitschrift)

The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.
Clausen, J; Kircher, B; Auberger, J; Schumacher, P; Ulmer, H; Hetzenauer, G; Wolf, D; Gastl, G; Nachbaur, D;
Biol Blood Marrow Transplant. 2010; 16(2): 273-280.
Originalarbeiten (Zeitschrift)

Management of venous thrombosis in fibular free osseomusculocutaneous flaps used for mandibular reconstruction: clinical techniques and treatment considerations
Draenert, FG; Gosau, M; Al Nawas, B
HEAD FACE MED. 2010; 6: 8
Editorials

Foetal hepatocyte transplantation in a vascularized AV-Loop transplantation model in the rat.
Fiegel, HC; Pryymachuk, G; Rath, S; Bleiziffer, O; Beier, JP; Bruns, H; Kluth, D; Metzger, R; Horch, RE; Till, H; Kneser, U;
J Cell Mol Med. 2010; 14(1-2):26-74
Originalarbeiten (Zeitschrift)

Dose intensity of chemotherapy in patients with relapsed Hodgkin"s lymphoma.
Josting, A; Müller, H; Borchmann, P; Baars, JW; Metzner, B; Döhner, H; Aurer, I; Smardova, L; Fischer, T; Niederwieser, D; Schäfer-Eckart, K; Schmitz, N; Sureda, A; Glossmann, J; Diehl, V; DeJong, D; Hansmann, ML; Raemaekers, J; Engert, A;
J Clin Oncol. 2010; 28(34): 5074-5080.
Originalarbeiten (Zeitschrift)

Fludarabine/intermediate-dose cytarabine with or without allogeneic hematopoietic stem cell transplantation in poor-risk leukemia: a single center experience.
Auberger, J; Clausen, J; Willenbacher, W; Erdel, M; Gunsilius, E; Petzer, A; Gastl, G; Nachbaur, D;
Int J Hematol. 2008; 87(4): 382-386.
Originalarbeiten (Zeitschrift)

First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation.
Auberger, J; Lass-Flörl, C; Clausen, J; Bellmann, R; Buzina, W; Gastl, G; Nachbaur, D;
Diagn Microbiol Infect Dis. 2008; 62(3): 336-339.
Fallberichte

Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure.
Bonaros, N; Rauf, R; Werner, E; Schlechta, B; Rohde, E; Kocher, A; Bonatti, J; Laufer, G;
Interact Cardiovasc Thorac Surg. 2008; 7(2):249-255
Originalarbeiten (Zeitschrift)

Ferritin and FasL (CD95L) mediate density dependent apoptosis in primary rat hepatocytes.
Bresgen, N; Ohlenschläger, I; Wacht, N; Afazel, S; Ladurner, G; Eckl, PM;
J Cell Physiol. 2008; 217(3): 800-808.
Originalarbeiten (Zeitschrift)

Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
Schetelig, J; Bornhäuser, M; Schmid, C; Hertenstein, B; Schwerdtfeger, R; Martin, H; Stelljes, M; Hegenbart, U; Schäfer-Eckart, K; Füssel, M; Wiedemann, B; Thiede, C; Kienast, J; Baurmann, H; Ganser, A; Kolb, HJ; Ehninger, G;
J Clin Oncol. 2008; 26(32):5183-5191
Originalarbeiten (Zeitschrift)

Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinsons disease.
Wernig, M; Zhao, JP; Pruszak, J; Hedlund, E; Fu, D; Soldner, F; Broccoli, V; Constantine-Paton, M; Isacson, O; Jaenisch, R;
Proc Natl Acad Sci U S A. 2008; 105(15):585-561
Originalarbeiten (Zeitschrift)

Vascular endothelial growth factor and activin-a serum levels following allogeneic hematopoietic stem cell transplantation.
Nachbaur, D; Schumacher, P; Auberger, J; Clausen, J; Kircher, B;
Biol Blood Marrow Transplant. 2007; 13(8):942-947
Originalarbeiten (Zeitschrift)

Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study.
Bornhäuser, M; Kröger, N; Schwerdtfeger, R; Schafer-Eckart, K; Sayer, HG; Scheid, C; Stelljes, M; Kienast, J; Mundhenk, P; Fruehauf, S; Kiehl, MG; Wandt, H; Theuser, C; Ehninger, G; Zander, AR;
Eur J Haematol. 2006; 76(1): 9-17.
Originalarbeiten (Zeitschrift)

The role of high-dose therapy in peripheral T-cell lymphomas
Reimer, P; Rudiger, T; Wilhelm, M
CLIN LYMPHOMA MYELOM. 2006; 6(5): 373-379.
Übersichtsarbeiten

Severe thrombocytopenia due to host-derived anti-HPA-1a after non-myeloablative allogeneic haematopoietic stem cell transplantation for multiple myeloma: a case report.
Macher, S; Schallmoser, K; Staber, PB; Neumeister, P; Posch, U; Lanzer, G; Panzer, S;
Vox Sang. 2005; 89(4):257-260
Originalarbeiten (Zeitschrift)

Hemosiderin deposits in chronic graft-vs.-host disease related myopathy
Schmidt-Hieber, M; Okuducu, AF; Stoltenburg, G; Mackert, BM; Benzian, N; Thiel, E; Blau, IW
EUR J HAEMATOL. 2005; 75(6): 522-526.
Fallberichte

Two allogeneic hematopoietic stem cell transplantations without the use of blood-product support
Wandt, H; Schaefer-Eckart, K; Wilhelm, M
HAEMATOL-HEMATOL J. 2005; 90(9): 1292-1294.
Letter

Polyinosinic-polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons.
Kunzmann, V; Kretzschmar, E; Herrmann, T; Wilhelm, M;
Immunology. 2004; 112(3):369-377
Originalarbeiten (Zeitschrift)

Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM).
Kröger, N; Einsele, H; Wolff, D; Casper, J; Freund, M; Derigs, G; Wandt, H; Schäfer-Eckart, K; Wittkowsky, G; Schmitz, N; Krüger, W; Zabelina, T; Renges, H; Ayuk, F; Krüll, A; Zander, A;
Bone Marrow Transplant. 2003; 31(11):973-979
Originalarbeiten (Zeitschrift)

What is CD4+CD56+malignancy and how should it be treated?
Reimer, P; Rudiger, T; Kraemer, D; Kunzmann, V; Weissinger, F; Zettl, A; Muller-Hermelink, HK; Wilhelm, M
BONE MARROW TRANSPL. 2003; 32(7): 637-646.
Übersichtsarbeiten

Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma.
Hänel, M; Kröger, N; Sonnenberg, S; Bornhäuser, M; Krüger, W; Kroschinsky, F; Hänel, A; Metzner, B; Birkmann, J; Schmid, B; Hoffknecht, MM; Fiedler, F; Ehninger, G; Zander, AR;
Ann Hematol. 2002; 81(2): 96-102.
Originalarbeiten (Zeitschrift)

Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma.
Kaiser, U; Uebelacker, I; Abel, U; Birkmann, J; Trümper, L; Schmalenberg, H; Karakas, T; Metzner, B; Hossfeld, DK; Bischoff, HG; Franke, A; Reiser, M; Müller, P; Mantovani, L; Grundeis, M; Rothmann, F; von Seydewitz, CU; Mesters, RM; Steinhauer, EU; Krahl, D; Schumacher, K; Kneba, M; Baudis, M; Schmitz, N; Pfab, R; Köppler, H; Parwaresch, R; Pfreundschuh, M; Havemann, K;
J Clin Oncol. 2002; 20(22): 4413-4419.
Originalarbeiten (Zeitschrift)

Involved-field irradiation in combination with total-body irradiation (TBI) does not increase short-term toxicity compared to TBI alone in patients with advanced-stage low-grade non-Hodgkin lymphoma.
Ott, M; Schmidberger, H; Wörmann, B; Albrecht, CF; Pradier, O; Hess, CF;
Strahlenther Onkol. 2002; 178(5): 245-251.
Originalarbeiten (Zeitschrift)

Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma.
Hänel, M; Kröger, N; Kroschinsky, F; Birkmann, J; Hänel, A; Herbst, R; Naumann, R; Friedrichsen, K; Ehninger, G; Zander, AR; Fiedler, F;
J Cancer Res Clin Oncol. 2001; 127(6):387-395
Originalarbeiten (Zeitschrift)

Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation.
Jenke, A; Renner, U; Richte, M; Freiberg-Richter, J; Platzbecker, U; Helwig, A; Thiede, HM; Schäfer-Eckart, K; Ehninger, G; Bornhäuser, M;
Clin Transplant. 2001; 15(3): 176-184.
Originalarbeiten (Zeitschrift)

Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin"s lymphoma.
Neumeister, P; Strunk, D; Apfelbeck, U; Sill, H; Linkesch, W
LANCET. 2000; 355(9212): 1334-1335.
Letter

The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications.
Goerner, M; Wandt, H; Schäfer-Eckart, K; Birkmann, J; Denzel, T; Gallmeier, WM;
J Hematother Stem Cell Res. 1999; 8(4): 387-391.
Originalarbeiten (Zeitschrift)

[High dose chemotherapy with autologous stem cell transplantation].
Weissinger, F; Reimer, P; Wilhelm, M;
Fortschr Med. 1997; 115(9): 39-43.
Übersichtsarbeiten